Takeda, Samsung Bioepis Partner to Develop Novel Biologic Therapies
Samsung Bioepis Co Ltd. will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co Ltd, expanding its business scope beyond copies of existing biologic drugs. Daniel Curran, head of the Centre for Innovation at Takeda, said: "At Takeda, we think differently - and creatively - about what makes a partnership successful and look to build on our strengths by collaborating with partners who have complementary expertise". Consulte Mais Informação